Alfentanil

This classification denotes an opioid receptor agonist and opioid with the molecular formula C21H32N6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1N74HM2BS7, chemically known as propanamide, n-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-4-(methoxymethyl)-4-piperidinyl)-n-phenyl- but generally known as alfentanil, which bears US NIH Compound Identifier 51263. Alfentanil most often comes in base and hydrochloride forms. European Medicines Agency schedules Alfentanil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05317MIG. The term ALFENTANIL is an International Non-Proprietary Name. World Health Organization schedules alfentanil in its Anatomical Therapeutic Chemical (ATC) Classification. ALFENTANIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alfentanil under HS 29333300 and SITC 51574. As of Q4 2014, ALFENTANIL remains the US FDA Preferred Term for this commodity. Alfentanil bears US NLM identifiers UMLS ID C0002026 and NCI Concept Code C61626. SMILES: O(CC1(N(C2CCCCC2)C(=O)CC)CCN(CC1)CCN1NNN(C1=O)CC)C.